SIMULTANEOUS DETERMINATION OF FENTANYL AND MIDAZOLAM IN PLASMA USING DIRECT SOLID-PHASE MICROEXTRACTION BEFORE GAS CHROMATOGRAPHY–MASS SPECTROMETRY ANALYSIS

ABSTRACT

We developed a rapid, specific, and sensitive solid-phase extraction method followed by gas chromatography–mass spectrometry analysis for the determination of fentanyl, midazolam or both drugs simultaneously in plasma samples. Various solid-phase microextraction fibres, extraction and desorption conditions were tested in the search of the best linearity, sensitivity and clean-up. The optimal solid-phase microextraction conditions were obtained with a new 65-µm polydimethylsiloxane/divinylbenzene (PDMS/DVB) fibre. Because of the high extraction selectivity and efficiency, the quantification limit for fentanyl and midazolam could be down to 0.8 ng mL⁻¹ and 1 ng mL⁻¹, respectively, for a plasma volume of 1 mL. The method described is sensitive enough for analysed fentanyl and midazolam in plasma samples for toxicological screening and therapeutic drug monitoring.

Keywords:

• Fentanyl
• Midazolam
• Solid-phase microextraction
• Gas chromatography
• Mass spectrometry
• Plasma sample

Acknowledgments